FTRE
Fortrea Holdings Inc.
$10.76
+$0.16(+1.51%)
36
Overall
60
Value
10
Tech
39
Quality
Market Cap
$1.03B
Volume
1.49M
52W Range
$3.97 - $18.67
Target Price
$12.65
Company Overview
| Mkt Cap | $1.03B | Price | $10.76 |
| Volume | 1.49M | Change | +1.51% |
| P/E Ratio | -3.1 | Open | $10.65 |
| Revenue | $2.7B | Prev Close | $10.60 |
| Net Income | $-328.5M | 52W Range | $3.97 - $18.67 |
| Div Yield | N/A | Target | $12.65 |
| Overall | 36 | Value | 60 |
| Quality | 39 | Technical | 10 |
No chart data available
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Latest News
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CSL (OtherCMXHF), Fortrea Holdings Inc. (FTRE) and Olympus (OtherOCPNF)
Brian Anderson•17 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FTRE | $10.76 | +1.5% | 1.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |